15 June 2016
Sponsored by:
In an effort to improve market access, companies are struggling to communicate the value of their product to customers and stakeholders. This webcast will help regulatory professionals think about how to use the drug development process to obtain those improvements. It is clear that market access—coverage and reimbursement for new life sciences products—increasingly has become almost as challenging and risky as the drug development and approval process. Stakeholders are demanding products that bring value to the market and to patients’ lives. It is essential companies start early to understand how stakeholders might value their products and to try to incorporate those views as the product is developed.
Learning Level:
Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.
Learning Objectives
Upon the webcast's conclusion, you will be able to:
Who Should Attend
All you need to participate in a webcast is Internet access and a telephone connection. Expert presenters virtually deliver the presentation via the Internet, while participants simultaneously view the PowerPoint slides on their own computers. A live Q&A portion following the presentation enables interaction between participants and presenters.